Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 2
2013 2
2017 1
2020 1
2021 2
2022 3
2023 2
2024 1
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer.
Hindes MT, McElligott AM, Best OG, Ward MP, Selemidis S, Miles MA, Nturubika BD, Gregory PA, Anderson PH, Logan JM, Butler LM, Waugh DJ, O'Leary JJ, Hickey SM, Thurgood LA, Brooks DA. Hindes MT, et al. Among authors: mcelligott am. Cancer Lett. 2025 Jan 2;611:217441. doi: 10.1016/j.canlet.2025.217441. Online ahead of print. Cancer Lett. 2025. PMID: 39755364 Free article. Review.
BRAF V600E-Negative Hairy Cell Leukaemia.
Langabeer SE, O'Brien D, McElligott AM, Lavin M, Browne PV. Langabeer SE, et al. Among authors: mcelligott am. Case Rep Hematol. 2013;2013:513049. doi: 10.1155/2013/513049. Epub 2013 Apr 9. Case Rep Hematol. 2013. PMID: 23653869 Free PMC article.
Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning.
Waldron C, O'Brien D, Brophy S, Perera K, Crotty GM, Dunlea E, Walsh A, Connolly M, Clifford R, O'Leary H, Khan A, Lee G, Atkinson E, Le G, Gillett A, Bacon CL, McElligott AM, Quinn F, Vandenberghe E. Waldron C, et al. Among authors: mcelligott am. Br J Haematol. 2022 Mar;196(5):e47-e49. doi: 10.1111/bjh.17929. Epub 2021 Nov 16. Br J Haematol. 2022. PMID: 34783371 No abstract available.
Synthesis and Biochemical Evaluation of Ethanoanthracenes and Related Compounds: Antiproliferative and Pro-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL).
McKeown JP, Byrne AJ, Bright SA, Charleton CE, Kandwal S, Čmelo I, Twamley B, McElligott AM, Fayne D, O'Boyle NM, Williams DC, Meegan MJ. McKeown JP, et al. Among authors: mcelligott am. Pharmaceuticals (Basel). 2024 Aug 5;17(8):1034. doi: 10.3390/ph17081034. Pharmaceuticals (Basel). 2024. PMID: 39204139 Free PMC article.
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals.
Elizabeth S, Aidan K, David OB, Deirdre W, Sarah B, Emer A, Kanthi P, Crotty GM, Aileen W, Michelle C, Ruth C, Hilary O, Ashique K, Bacon CL, Emily S, McElligott AM, Fiona Q, Elisabeth V, Carmel W. Elizabeth S, et al. Among authors: mcelligott am. Eur J Haematol. 2022 Nov;109(5):441-446. doi: 10.1111/ejh.13824. Epub 2022 Aug 9. Eur J Haematol. 2022. PMID: 35776688 Free PMC article.
A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma.
Amet R, Previtali V, Mihigo HB, Sheridan E, Brophy S, Hante NK, Santos-Martinez MJ, Hayden PJ, Browne PV, Rozas I, McElligott AM, Zisterer DM. Amet R, et al. Among authors: mcelligott am. Life Sci. 2022 Feb 1;290:120236. doi: 10.1016/j.lfs.2021.120236. Epub 2021 Dec 22. Life Sci. 2022. PMID: 34953891
19 results